You're watching...
FOX News Medical Contributor Dr. Marc Siegel on what we can learn about pancreatic cancer from the former Apple CEO.
Also in this playlist...
Auto-advance: ON
Auto-advance
This transcript is automatically generated
Joining -- company announced fox medical contributor doctor Marc Siegel.
Doctor Steve Jobs announced back in 2000 -- He had surgery to remove a cancerous tumor from his -- -- so.
This is a long time for someone to live with such an aggressive form of cancer now.
Charles we owe it to Steve Jobs to be very accurate about this -- He was in 2040 city had that kind of pancreatic cancer that only 1% of people have.
The pancreas is divided into two parts one part helps in digestion that's what you think of when you think of patriotic cancer those are really deadly in lethal He would have that kind.
He had the kind -- related to hormones the islet cell cancer that's very hard to predict what it's gonna do it can be very lethal or can be not lethal.
Very rarely is anyone ever get a liver transplant from this kind of a cancer and so that's the point though it's still was an aggressive form of cancer maybe not as aggressive as the other -- there were any still hat.
Maybe something akin to a revolutionary form of of treatment -- Charles let's very well put.
When it spreads to deliver it about 40% of people -- five years from that point to give you an idea that's actually much better than -- the other kind of -- cancer.
Very rarely does anyone ever get a liver transplant for this may be because He was Steve Jobs I can't prove that but I that's on my mind.
It's very hard at the get a liver transplant when your kids you've got to get immune suppressive drugs it's very hard to live and after that we don't know the statistics on this but it is not good when that cancer spreads to the -- You know they try to pick off of it passed the season remove them if they can't.
You could get a liver transplant but very hard to get to the front of the line with -- well it's it's obvious though that He He you have treatment and you know He lived much longer people maybe thought He would.
So they -- the question now was this treatment that He had -- -- something that ultimately could be available to the masses.
What is available to the masses except for the liver transplant.
I think we're moving in the direction of genetic therapy a few years from now we me a -- may be able to correct something before the cancer gets where there's.
And by the -- of one -- -- I want to address a business question that's come up here everybody's been saying should we have told the stockholders more should have told them more more disclosure.
I think we've proven today this -- cancer that He had was so elusive.
That it was all about probabilities and statistics very hard to predict so I don't think He really had a telling -- more than just.
The gentleman who recently a scientist who -- -- posthumously the Nobel Prize for science.
He died and -- cancer different kind of argued -- I'm working yes to save his own line with a vaccine.
Will there be vaccines for this.
There may very well be Greg you know what they're doing the turning the immune system against the cancer they're saying this is far this cancer let's get rid of -- almost always treated infection.
And that's the direction we're going with cancer vaccines.
That may very well happen.
Five or ten years from -- are you gonna see that unfortunately He was -- He was in there but the bottom line -- that I but that's the general public -- Steve Jobs probably had treatment that that's out of their reach from for the moment.
Only when you talk about liver transplant everything else you got standard of care they liver transplant was beyond standard of care doctor Marc Siegel thank you very much -- Asian --
